Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma

Published:2023-01 Issue: Volume:552 Page:215970
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Xu Jiali,Zhang Liren,Li Nana,Dai Jingjing,Zhang Ruizhi,Yao Feifan,Zhou Suiqing,Wu Zifeng,Zhou Huixuan,Zhou Ling,Li Qing,Wang Xuehao,Liu Cunming

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Hepatocellular Carcinoma;Vogel,2022

2. Epidemiology of hepatocellular carcinoma;McGlynn;Hepatology,2021

3. Current status of gene therapy in hepatocellular carcinoma;Reghupaty;Cancers,2019

4. Surgical treatments of hepatobiliary cancers;Gunasekaran;Hepatology,2021

5. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis;Dubowitz;Clin. Exp. Metastasis,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma;Cancer Letters;2024-07

2. Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma;iScience;2024-06

3. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer;Frontiers in Oncology;2024-04-18

4. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer;Molecular and Cellular Biochemistry;2024-03-22

5. Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway;Neurochemical Research;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3